Invitrogen™ ELOVL2 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5103826

Catalog No. PIPA5103826

Description

Antibody detects endogenous levels of total ELOVL2.

ELOVL2 could be implicated in tissue-specific synthesis of very long chain fatty acids and sphingolipids. This protein may catalyze one or both of the reduction reaction in fatty acid elongation, i. e., conversion of beta-ketoacyl CoA to beta-hydroxyacyl CoA or reduction of trans-2-enoyl CoA to the saturated acyl CoA derivative.

Specifications

• Antigen: ELOVL2
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: ELOVL2
• Gene Alias: 3-keto acyl-CoA synthase ELOVL2; AI317360; ELG3; elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 2; elongation of very long chain fatty acids protein 2; elongation of very long chain fatty acids-like 2; ELOVL FA elongase 2; ELOVL family member 2; ELOVL fatty acid elongase 2; Elovl2; sequence similarity to Cig30 2; SSC2; Very long chain 3-ketoacyl-CoA synthase 2; very long chain 3-oxoacyl-CoA synthase 2; very-long-chain 3-oxoacyl-CoA synthase 2
• Host Species: Rabbit
• Purification Method: Affinity chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 54898
• Content And Storage: -20°C
• Form: Liquid

• Applications: Western Blot
• Concentration: 1 mg/mL
• Formulation: PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
• Gene Accession No.: Q9NXB9
• Gene Symbols: ELOVL2
• Immunogen: A synthesized peptide derived from human ELOVL2(Accession Q9NXB9), corresponding to amino acid residues L32-M82.
• Quantity: 100 μL
• Primary or Secondary: Primary
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov